DK1127571T3 - Anvendelse af sertralin til at behandle posttraumatisk stresssygdom - Google Patents

Anvendelse af sertralin til at behandle posttraumatisk stresssygdom

Info

Publication number: DK1127571T3
Authority: DK; Denmark
Prior art keywords: sertraline; stress disorder; traumatic stress; treat post; treat
Prior art date: 1989-11-02

Application number

DK01103962T

Other languages

Danish (da)

English (en)

Inventor

Declan P Doogan

Karen A Scappaticci

Elizabeth Hackett

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-11-02

Filing date

1990-10-29

Publication date

2004-09-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23710001&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1127571(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1990-10-29 Application filed by Pfizer filed Critical Pfizer

2004-09-20 Application granted granted Critical

2004-09-20 Publication of DK1127571T3 publication Critical patent/DK1127571T3/da

Links

VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 title abstract 2
208000028173 post-traumatic stress disease Diseases 0.000 title 1
229960002073 sertraline Drugs 0.000 title 1
206010041250 Social phobia Diseases 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Anesthesiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK01103962T 1989-11-02 1990-10-29 Anvendelse af sertralin til at behandle posttraumatisk stresssygdom DK1127571T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/431,000 US4962128A (en)	1989-11-02	1989-11-02	Method of treating anxiety-related disorders using sertraline

Publications (1)

Publication Number	Publication Date
DK1127571T3 true DK1127571T3 (da)	2004-09-20

Family

ID=23710001

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DK01103962T DK1127571T3 (da)	1989-11-02	1990-10-29	Anvendelse af sertralin til at behandle posttraumatisk stresssygdom
DK01103959T DK1129708T3 (da)	1989-11-02	1990-10-29	Sertralin til behandling af social fobi
DK90311797T DK0429189T3 (da)	1989-11-02	1990-10-29	Anvendelse af sertralin til fremstilling af et lægemiddel til behandling af obsessiv-kompulsive sygdomme

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
DK01103959T DK1129708T3 (da)	1989-11-02	1990-10-29	Sertralin til behandling af social fobi
DK90311797T DK0429189T3 (da)	1989-11-02	1990-10-29	Anvendelse af sertralin til fremstilling af et lægemiddel til behandling af obsessiv-kompulsive sygdomme

Country Status (17)

Country	Link
US (1)	US4962128A (fr)
EP (4)	EP1125581A1 (fr)
JP (1)	JPH03153624A (fr)
KR (1)	KR960016580B1 (fr)
AT (3)	ATE212223T1 (fr)
AU (1)	AU616127B2 (fr)
CA (1)	CA2029065C (fr)
DE (3)	DE69034149T2 (fr)
DK (3)	DK1127571T3 (fr)
HU (1)	HUT59305A (fr)
IE (4)	IE20020410A1 (fr)
IL (1)	IL96146A (fr)
MY (1)	MY106075A (fr)
NZ (1)	NZ235933A (fr)
PH (1)	PH26836A (fr)
PT (1)	PT95760B (fr)
ZA (1)	ZA908768B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE96999T1 (de) *	1989-08-30	1993-11-15	Pfizer	Verwendung von sertralin zur behandlung von abhaengigkeiten von chemischen stoffen.
US4940731A (en) *	1989-08-30	1990-07-10	Pfizer Inc.	Method of treating premature ejaculation using sertraline
WO1992002215A1 (fr) *	1990-08-09	1992-02-20	Massachusetts Institute Of Technology	Methodes servant a traiter le syndrome premenstruel ou le syndrome de l'insuffisance luteale
US5457100A (en) *	1991-12-02	1995-10-10	Daniel; David G.	Method for treatment of recurrent paroxysmal neuropsychiatric
US5597826A (en)	1994-09-14	1997-01-28	Pfizer Inc.	Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
US5525347A (en) *	1995-01-31	1996-06-11	Medical University Of South Carolina	Composition and methods for treating performance anxiety
US20040208926A1 (en) *	1997-07-01	2004-10-21	Pfizer Inc	Solubilized sertraline compositions
CA2290966C (fr)	1997-07-01	2005-12-20	Pfizer Inc.	Sels de sertraline et formes posologiques de sertraline, a liberation prolongee
US20030133974A1 (en) *	1997-07-01	2003-07-17	Curatolo William John	Encapsulated solution dosage forms of sertraline
AU761618B2 (en) *	1997-07-01	2003-06-05	Pfizer Inc.	Sertraline salts and sustained-release dosage forms of sertraline
US6391922B1 (en)	1998-01-13	2002-05-21	Synchroneuron, Llc	Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders
DE19830201A1 (de) *	1998-07-07	2000-01-13	Boehringer Ingelheim Pharma	Mittel mit antidepressiver Wirkung
US6727283B2 (en) *	1998-10-13	2004-04-27	Pfizer Inc.	Sertraline oral concentrate
ES2209490T3 (es) *	1998-10-13	2004-06-16	Pfizer Products Inc.	Concentrado oral de sertralina.
IL132500A0 (en)	1998-10-29	2001-03-19	Pfizer Prod Inc	Stereoselective microbial reduction of a racemic tetralone
US6245782B1 (en)	1999-05-17	2001-06-12	Heartdrug Research L.L.C.	Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
AR021155A1 (es) *	1999-07-08	2002-06-12	Lundbeck & Co As H	Tratamiento de desordenes neuroticos
JP2003518487A (ja)	1999-12-23	2003-06-10	ファイザー・プロダクツ・インク	ヒドロゲル駆動型積層薬物製剤
WO2002087566A1 (fr) *	2001-05-01	2002-11-07	H. Lundbeck A/S	Utilisation d'escitalopram pur enantiomere
US20030119908A1 (en) *	2001-12-21	2003-06-26	Zambon Group S.P.A.	Stable gabapentin compositions
EP2316468A1 (fr)	2002-02-22	2011-05-04	Shire LLC	Système de distribution et méthodes de protection et d'administration de dextroamphetamine
US20040131672A1 (en) *	2003-01-07	2004-07-08	Nilobon Podhipleux	Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
US20050070577A1 (en) *	2003-07-03	2005-03-31	Pfizer Inc.	Compositions containing a serotonin selective reuptake inhibitor and a 5-HT2A receptor antagonist
EP1737473A4 (fr) *	2004-04-19	2009-08-26	Noven Therapeutics Llc	Combinaisons de lithium et utilisations associees
MXPA06012777A (es) *	2004-05-06	2007-02-14	Cydex Inc	Formulaciones de sabor enmascarado que contienen sertralina y eter sulfoalquilico-ciclodextrina.
US7893053B2 (en) *	2006-06-16	2011-02-22	Theracos, Inc.	Treating psychological conditions using muscarinic receptor M1 antagonists
US20060257475A1 (en) *	2006-08-17	2006-11-16	Boehringer Ingelheim International Gmbh	Stable Sertraline Hydrochloride Formulation and Method
GB0708818D0 (en) *	2007-05-08	2007-06-13	Portela & Ca Sa	Compounds
US9283212B2 (en)	2009-02-20	2016-03-15	Palmaya Pty Ltd	Pharmaceutical preparation and delivery system
US20100298397A1 (en) *	2009-05-19	2010-11-25	Singh Nikhilesh N	Method of treatment of obsessive compulsive disorder with ondansetron
EP2875810A1 (fr) *	2013-11-20	2015-05-27	Biocodex	Traitement pharmacologique de trouble obsessionnel compulsif en utilisant du Stiripentole ou d'un composé similaire
GB2630572A (en)	2023-05-29	2024-12-04	Novumgen Ltd	An orally disintegrating tablet of sertraline and its process of preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4536518A (en) *	1979-11-01	1985-08-20	Pfizer Inc.	Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4803076A (en) *	1986-09-04	1989-02-07	Pfizer Inc.	Controlled release device for an active substance
JP2938463B2 (ja) *	1987-10-22	1999-08-23	マサチユセツツ・インスチチユート・オブ・テクノロジー	月経前又は後期黄体期症候群の処置
IL91398A (en) *	1988-08-30	1994-05-30	Pfizer	Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane

1989
- 1989-11-02 US US07/431,000 patent/US4962128A/en not_active Expired - Lifetime
1990
- 1990-10-28 IL IL9614690A patent/IL96146A/en not_active IP Right Cessation
- 1990-10-29 PH PH41458A patent/PH26836A/en unknown
- 1990-10-29 EP EP01103963A patent/EP1125581A1/fr not_active Ceased
- 1990-10-29 DE DE69034149T patent/DE69034149T2/de not_active Revoked
- 1990-10-29 AT AT90311797T patent/ATE212223T1/de not_active IP Right Cessation
- 1990-10-29 DE DE69033903T patent/DE69033903D1/de not_active Revoked
- 1990-10-29 DK DK01103962T patent/DK1127571T3/da active
- 1990-10-29 DE DE69034223T patent/DE69034223T2/de not_active Revoked
- 1990-10-29 EP EP01103962A patent/EP1127571B1/fr not_active Revoked
- 1990-10-29 DK DK01103959T patent/DK1129708T3/da active
- 1990-10-29 AT AT01103959T patent/ATE327743T1/de not_active IP Right Cessation
- 1990-10-29 EP EP90311797A patent/EP0429189B1/fr not_active Revoked
- 1990-10-29 EP EP01103959A patent/EP1129708B1/fr not_active Revoked
- 1990-10-29 DK DK90311797T patent/DK0429189T3/da active
- 1990-10-29 AT AT01103962T patent/ATE269068T1/de not_active IP Right Cessation
- 1990-10-31 PT PT95760A patent/PT95760B/pt not_active IP Right Cessation
- 1990-10-31 JP JP2295130A patent/JPH03153624A/ja active Pending
- 1990-10-31 CA CA002029065A patent/CA2029065C/fr not_active Expired - Lifetime
- 1990-11-01 IE IE20020410A patent/IE20020410A1/en not_active IP Right Cessation
- 1990-11-01 IE IE20020411A patent/IE20020411A1/en unknown
- 1990-11-01 KR KR1019900017691A patent/KR960016580B1/ko not_active Expired - Fee Related
- 1990-11-01 MY MYPI90001915A patent/MY106075A/en unknown
- 1990-11-01 IE IE20020409A patent/IE20020409A1/en unknown
- 1990-11-01 AU AU65715/90A patent/AU616127B2/en not_active Ceased
- 1990-11-01 ZA ZA908768A patent/ZA908768B/xx unknown
- 1990-11-01 IE IE393690A patent/IE903936A1/en not_active IP Right Cessation
- 1990-11-01 NZ NZ235933A patent/NZ235933A/en unknown
- 1990-11-02 HU HU907011A patent/HUT59305A/hu unknown

Also Published As

Publication number	Publication date
CA2029065A1 (fr)	1991-05-03
DE69034223D1 (de)	2006-07-06
EP1127571A1 (fr)	2001-08-29
HU907011D0 (en)	1991-05-28
ATE212223T1 (de)	2002-02-15
PT95760B (pt)	1997-12-31
EP1129708B1 (fr)	2006-05-31
JPH03153624A (ja)	1991-07-01
EP1129708A1 (fr)	2001-09-05
EP0429189B1 (fr)	2002-01-23
EP0429189A2 (fr)	1991-05-29
IE20020410A1 (en)	2002-11-27
DE69034223T2 (de)	2006-11-02
DE69034149D1 (de)	2004-07-22
IE20020411A1 (en)	2002-11-27
DE69033903D1 (de)	2002-03-14
US4962128A (en)	1990-10-09
IE20020409A1 (en)	2002-11-27
ATE327743T1 (de)	2006-06-15
MY106075A (en)	1995-03-31
IL96146A0 (en)	1991-07-18
IE903936A1 (en)	1991-05-08
IL96146A (en)	1995-10-31
DK0429189T3 (da)	2002-02-11
ATE269068T1 (de)	2004-07-15
DE69034149T2 (de)	2004-09-30
AU616127B2 (en)	1991-10-17
PT95760A (pt)	1991-09-13
HUT59305A (en)	1992-05-28
DK1129708T3 (da)	2006-08-07
KR960016580B1 (ko)	1996-12-16
CA2029065C (fr)	1994-11-08
PH26836A (en)	1992-11-05
KR910009252A (ko)	1991-06-28
EP0429189A3 (en)	1992-01-22
ZA908768B (en)	1992-06-24
EP1125581A1 (fr)	2001-08-22
EP1127571B1 (fr)	2004-06-16
NZ235933A (en)	1997-07-27
AU6571590A (en)	1991-08-01

Publication	Publication Date	Title
DK1127571T3 (da)	2004-09-20	Anvendelse af sertralin til at behandle posttraumatisk stresssygdom
DK0415613T3 (da)	1994-10-10	Anvendelse af sertralin til behandling af præmatur ejakulation
MX9205681A (es)	1993-04-01	Aminometil-cromanos, procedimiento para su fabricacion y medicamento que los contiene.
NO944377D0 (no)	1994-11-16	Kjölemiddelblandinger
KR880012218A (ko)	1988-11-26	캘폰 유도체를 사용한 다발성 경화증의 치료방법
GB2368283A (en)	2002-05-01	Cyclobenzaprine for treating generalized anxiety disorder and compositions thereof
DK0687177T3 (da)	1997-02-10	Anvendelse af lamotrigin ved fremstilling af lægemidler til behandling af AIDS-relaterede nervesygdomme
BR0209845A (pt)	2004-08-24	Formas de dosagem de oxcarbazepina e processo para a preparação das mesmas
YU78701A (sh)	2004-03-12	Tretiranje neurotskih poremećaja
DK0966277T3 (da)	2006-03-27	Anvendelse af R-NSAID'er til forebyggelse af Alzheimer's sygdom
DE69423577D1 (de)	2000-04-27	Verwendung von Oenothein B zur Herstellung eines Medikaments zur Behandlung der durch Hyperandrogenität bedingte Störungen.
DK0768083T3 (da)	2003-06-23	Anvendelse af sertralin til at behandle patienter med post myocardisk infarkt
DK0651648T3 (da)	2003-01-06	Farmaceutisk præparat indeholdende IL-6. Anvendelse deraf til behandling af konsumptiv trombo-hæmoragisk sygdom
MY106939A (en)	1995-08-30	A method of treating chemical dependencies using sertraline.
ES2093515T3 (es)	1996-12-16	Aplicacion del riluzol como radio-restaurador.
PT930879E (pt)	2003-01-31	Utilizacao de dobesilato de calcio para a preparacao de um medicamento para o tratamento de retardamento embrionario
MX9602793A (es)	1998-01-31	Uso de sertralina para tratar pacientes despues de un infarto de miocardio.
KR950013350U (ko)	1995-06-15	졸음·스트레스 방지용 링